[{"id":"f3a57e99-36b8-4856-b1b8-be1b041c0803","acronym":"","url":"https://clinicaltrials.gov/study/NCT07048847","created_at":"2025-07-05T13:56:07.976Z","updated_at":"2025-07-05T13:56:07.976Z","phase":"","brief_title":"The Effect of Aerobic Exercise on Selective Biomarkers of Patients With Cancer","source_id_and_acronym":"NCT07048847","lead_sponsor":"Izmir Bakircay University","biomarkers":" LEP","pipe":"","alterations":" ","tags":["LEP"],"overall_status":"Completed","enrollment":" Enrollment 32","initiation":"Initiation: 09/15/2022","start_date":" 09/15/2022","primary_txt":" Primary completion: 08/15/2023","primary_completion_date":" 08/15/2023","study_txt":" Completion: 12/01/2023","study_completion_date":" 12/01/2023","last_update_posted":"2025-07-03"},{"id":"198522b7-100a-4569-a5b1-c2c7d2835c3e","acronym":"","url":"https://clinicaltrials.gov/study/NCT06195306","created_at":"2024-01-08T16:17:49.869Z","updated_at":"2025-02-25T13:42:01.381Z","phase":"Phase 2","brief_title":"Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction","source_id_and_acronym":"NCT06195306","lead_sponsor":"National Cancer Institute (NCI)","biomarkers":" FOXA1 • AGR2 • LEP","pipe":"","alterations":" ","tags":["FOXA1 • AGR2 • LEP"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e tamoxifen"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 66","initiation":"Initiation: 02/28/2025","start_date":" 02/28/2025","primary_txt":" Primary completion: 01/01/2027","primary_completion_date":" 01/01/2027","study_txt":" Completion: 01/01/2027","study_completion_date":" 01/01/2027","last_update_posted":"2025-02-21"},{"id":"b512d1ec-5eed-4af0-ad6e-074e6046eff9","acronym":"","url":"https://clinicaltrials.gov/study/NCT06540612","created_at":"2025-02-27T08:02:01.646Z","updated_at":"2025-02-27T08:02:01.646Z","phase":"","brief_title":"Effects of Aerobic Exercise on Cancer-Related Biomarkers, Functional Capacity, Cognitive Status and Quality of Life in Women With Breast Cancer","source_id_and_acronym":"NCT06540612","lead_sponsor":"Hasan Kalyoncu University","biomarkers":" IL6 • TNFA • IGF1 • LEP","pipe":"","alterations":" ","tags":["IL6 • TNFA • IGF1 • LEP"],"overall_status":"Enrolling by invitation","enrollment":" Enrollment 69","initiation":"Initiation: 05/15/2024","start_date":" 05/15/2024","primary_txt":" Primary completion: 06/01/2025","primary_completion_date":" 06/01/2025","study_txt":" Completion: 08/15/2025","study_completion_date":" 08/15/2025","last_update_posted":"2024-08-09"},{"id":"853b2c7a-ae04-4c10-89b6-0e2751505bec","acronym":"","url":"https://clinicaltrials.gov/study/NCT04812652","created_at":"2024-05-04T04:26:52.545Z","updated_at":"2024-07-02T16:35:06.634Z","phase":"","brief_title":"Digitally Distributed Yoga for Women Treated for Breast Cancer","source_id_and_acronym":"NCT04812652","lead_sponsor":"Region Örebro County","biomarkers":" TNFA • CXCL8 • IGF1 • IGF2 • IL1B • LEP","pipe":"","alterations":" ","tags":["TNFA • CXCL8 • IGF1 • IGF2 • IL1B • LEP"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 229","initiation":"Initiation: 10/01/2021","start_date":" 10/01/2021","primary_txt":" Primary completion: 05/01/2024","primary_completion_date":" 05/01/2024","study_txt":" Completion: 07/01/2026","study_completion_date":" 07/01/2026","last_update_posted":"2024-05-01"},{"id":"bbbbde50-86df-4089-8d78-2db1a196b549","acronym":"MMF","url":"https://clinicaltrials.gov/study/NCT03971591","created_at":"2021-01-18T19:32:17.276Z","updated_at":"2024-07-02T16:35:32.558Z","phase":"","brief_title":"Men Moving Forward: A Lifestyle Program for African-American Prostate Cancer Survivors","source_id_and_acronym":"NCT03971591 - MMF","lead_sponsor":"Medical College of Wisconsin","biomarkers":" IL6 • IGF1 • LEP","pipe":"","alterations":" ","tags":["IL6 • IGF1 • LEP"],"overall_status":"Recruiting","enrollment":" Enrollment 200","initiation":"Initiation: 06/01/2019","start_date":" 06/01/2019","primary_txt":" Primary completion: 06/30/2024","primary_completion_date":" 06/30/2024","study_txt":" Completion: 06/30/2024","study_completion_date":" 06/30/2024","last_update_posted":"2023-10-19"},{"id":"921fd2a9-c5b3-4b69-a147-e1e3d7a99e3c","acronym":"LL-PTC","url":"https://clinicaltrials.gov/study/NCT01659385","created_at":"2021-01-18T07:09:52.356Z","updated_at":"2024-07-02T16:35:38.027Z","phase":"","brief_title":"Leptin Levels in Papillary Thyroid Cancer","source_id_and_acronym":"NCT01659385 - LL-PTC","lead_sponsor":"University of Nebraska","biomarkers":" LEP","pipe":"","alterations":" ","tags":["LEP"],"overall_status":"Completed","enrollment":" Enrollment 18","initiation":"Initiation: 08/07/2012","start_date":" 08/07/2012","primary_txt":" Primary completion: 04/25/2013","primary_completion_date":" 04/25/2013","study_txt":" Completion: 04/25/2013","study_completion_date":" 04/25/2013","last_update_posted":"2023-09-06"},{"id":"630319d6-7476-4345-9ba2-bdb41e52946d","acronym":"BWEL","url":"https://clinicaltrials.gov/study/NCT02750826","created_at":"2021-01-18T13:28:41.714Z","updated_at":"2024-07-02T16:35:38.388Z","phase":"Phase 3","brief_title":"Breast Cancer WEight Loss Study (BWEL Study)","source_id_and_acronym":"NCT02750826 - BWEL","lead_sponsor":"Alliance for Clinical Trials in Oncology","biomarkers":" HER-2 • ER • PGR • IL6 • TNFA • IGF1 • IGFBP3 • LEP","pipe":" | ","alterations":" HER-2 positive • HR positive • PGR positive","tags":["HER-2 • ER • PGR • IL6 • TNFA • IGF1 • IGFBP3 • LEP"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 positive • HR positive • PGR positive"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 3177","initiation":"Initiation: 08/01/2016","start_date":" 08/01/2016","primary_txt":" Primary completion: 05/01/2030","primary_completion_date":" 05/01/2030","study_txt":"","study_completion_date":"","last_update_posted":"2023-08-31"},{"id":"9b921629-b363-4277-8b9e-a90c374a89f8","acronym":"","url":"https://clinicaltrials.gov/study/NCT02598557","created_at":"2021-01-18T12:36:50.747Z","updated_at":"2024-07-02T16:35:39.401Z","phase":"Phase 2","brief_title":"Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen Positive Breast Cancer","source_id_and_acronym":"NCT02598557","lead_sponsor":"National Cancer Institute (NCI)","biomarkers":" ER • LEP","pipe":" | ","alterations":" ER positive • PGR expression","tags":["ER • LEP"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ER positive • PGR expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e exemestane"],"overall_status":"Completed","enrollment":" Enrollment 180","initiation":"Initiation: 12/06/2016","start_date":" 12/06/2016","primary_txt":" Primary completion: 10/03/2019","primary_completion_date":" 10/03/2019","study_txt":" Completion: 02/02/2023","study_completion_date":" 02/02/2023","last_update_posted":"2023-08-22"},{"id":"dc1b521e-0996-412e-ab38-e1a04712537f","acronym":"","url":"https://clinicaltrials.gov/study/NCT03953157","created_at":"2021-01-18T19:27:23.981Z","updated_at":"2024-07-02T16:35:43.510Z","phase":"","brief_title":"Dietary and Exercise Interventions in Reducing Side Effects in Patients With Stage I-IIIa Breast Cancer Receiving Aromatase Inhibitors","source_id_and_acronym":"NCT03953157","lead_sponsor":"Jonsson Comprehensive Cancer Center","biomarkers":" IL6 • CXCL8 • TGFB1 • IL1B • LEP","pipe":"","alterations":" ","tags":["IL6 • CXCL8 • TGFB1 • IL1B • LEP"],"overall_status":"Recruiting","enrollment":" Enrollment 20","initiation":"Initiation: 10/07/2019","start_date":" 10/07/2019","primary_txt":" Primary completion: 06/01/2024","primary_completion_date":" 06/01/2024","study_txt":" Completion: 06/01/2025","study_completion_date":" 06/01/2025","last_update_posted":"2023-07-10"},{"id":"bb9997f0-453a-4083-9fab-d8017d881de5","acronym":"1R01CA172444-01A1","url":"https://clinicaltrials.gov/study/NCT02028221","created_at":"2021-01-18T09:17:16.755Z","updated_at":"2024-07-02T16:35:44.648Z","phase":"Phase 2","brief_title":"Phase II Study of Metformin for Reduction of Obesity-Associated Breast Cancer Risk","source_id_and_acronym":"NCT02028221 - 1R01CA172444-01A1","lead_sponsor":"University of Arizona","biomarkers":" IGF1 • IGF2 • IGFBP3 • LEP","pipe":"","alterations":" ","tags":["IGF1 • IGF2 • IGFBP3 • LEP"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e metformin"],"overall_status":"Completed","enrollment":" Enrollment 151","initiation":"Initiation: 03/07/2014","start_date":" 03/07/2014","primary_txt":" Primary completion: 11/30/2018","primary_completion_date":" 11/30/2018","study_txt":" Completion: 06/14/2022","study_completion_date":" 06/14/2022","last_update_posted":"2023-06-27"},{"id":"9d5e15d6-9cc9-4fe2-ab8a-871c8f054a86","acronym":"","url":"https://clinicaltrials.gov/study/NCT04697264","created_at":"2021-01-19T20:49:48.942Z","updated_at":"2024-07-02T16:35:46.802Z","phase":"","brief_title":"Adipocytokines in Endometrial Cancer","source_id_and_acronym":"NCT04697264","lead_sponsor":"University of Surrey","biomarkers":" IL6 • IGF1 • LEP","pipe":"","alterations":" ","tags":["IL6 • IGF1 • LEP"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 60","initiation":"Initiation: 04/12/2021","start_date":" 04/12/2021","primary_txt":" Primary completion: 10/01/2024","primary_completion_date":" 10/01/2024","study_txt":" Completion: 10/01/2024","study_completion_date":" 10/01/2024","last_update_posted":"2023-05-31"},{"id":"7d6a62be-44ac-45b9-9fe6-06206c82f61d","acronym":"DISCO","url":"https://clinicaltrials.gov/study/NCT03529383","created_at":"2021-01-18T17:22:33.688Z","updated_at":"2024-07-02T16:35:52.725Z","phase":"","brief_title":"Efficacy of Exercise Using Connected Activity Trackers and Therapeutic Education in Localized Breast Cancer","source_id_and_acronym":"NCT03529383 - DISCO","lead_sponsor":"Centre Leon Berard","biomarkers":" IL6 • IGF1 • LEP","pipe":"","alterations":" ","tags":["IL6 • IGF1 • LEP"],"overall_status":"Completed","enrollment":" Enrollment 436","initiation":"Initiation: 05/18/2018","start_date":" 05/18/2018","primary_txt":" Primary completion: 03/04/2022","primary_completion_date":" 03/04/2022","study_txt":" Completion: 09/23/2022","study_completion_date":" 09/23/2022","last_update_posted":"2023-03-22"},{"id":"28282b71-ae34-40ff-b2a3-ac80bdac7448","acronym":"METAB-OV","url":"https://clinicaltrials.gov/study/NCT05007834","created_at":"2021-08-16T16:54:49.663Z","updated_at":"2024-07-02T16:35:54.181Z","phase":"","brief_title":"Metabolism, Circadian Rhythms and Ovarian Function","source_id_and_acronym":"NCT05007834 - METAB-OV","lead_sponsor":"University Hospital, Lille","biomarkers":" IL6 • LEP","pipe":"","alterations":" ","tags":["IL6 • LEP"],"overall_status":"Recruiting","enrollment":" Enrollment 50","initiation":"Initiation: 02/24/2022","start_date":" 02/24/2022","primary_txt":" Primary completion: 02/01/2025","primary_completion_date":" 02/01/2025","study_txt":" Completion: 02/01/2025","study_completion_date":" 02/01/2025","last_update_posted":"2023-03-03"},{"id":"4440793a-ab83-4b82-b144-f3e5b46b6fe3","acronym":"","url":"https://clinicaltrials.gov/study/NCT05748704","created_at":"2023-03-01T15:01:57.757Z","updated_at":"2024-07-02T16:35:54.508Z","phase":"Phase 1","brief_title":"Metabolic and Immunological Effects of a Modified Fasting Regimen in Cancer Patients","source_id_and_acronym":"NCT05748704","lead_sponsor":"University of Genova","biomarkers":" CD8 • IL6 • TNFA • IL2RA • PTPRC • IGF1 • NCAM1 • ENTPD1 • IGFBP3 • IL1B • IGFBP1 • ISG20 • LEP","pipe":"","alterations":" ","tags":["CD8 • IL6 • TNFA • IL2RA • PTPRC • IGF1 • NCAM1 • ENTPD1 • IGFBP3 • IL1B • IGFBP1 • ISG20 • LEP"],"overall_status":"Recruiting","enrollment":" Enrollment 100","initiation":"Initiation: 11/01/2021","start_date":" 11/01/2021","primary_txt":" Primary completion: 11/01/2025","primary_completion_date":" 11/01/2025","study_txt":" Completion: 11/01/2025","study_completion_date":" 11/01/2025","last_update_posted":"2023-03-01"},{"id":"c4731e51-7766-4350-abdf-25fad48c4b2c","acronym":"LEAN 2","url":"https://clinicaltrials.gov/study/NCT02110641","created_at":"2021-01-18T09:45:38.107Z","updated_at":"2024-07-02T16:35:55.183Z","phase":"","brief_title":"Lifestyle, Exercise and Nutrition Study 2 (LEAN 2)","source_id_and_acronym":"NCT02110641 - LEAN 2","lead_sponsor":"Yale University","biomarkers":" HER-2 • ER • PGR • IGF1 • IR • CRP • LEP","pipe":"","alterations":" ","tags":["HER-2 • ER • PGR • IGF1 • IR • CRP • LEP"],"overall_status":"Completed","enrollment":" Enrollment 51","initiation":"Initiation: 11/01/2013","start_date":" 11/01/2013","primary_txt":" Primary completion: 02/01/2016","primary_completion_date":" 02/01/2016","study_txt":" Completion: 02/01/2016","study_completion_date":" 02/01/2016","last_update_posted":"2023-02-20"},{"id":"2e93d2a2-8106-4316-bd36-96c9898a94a7","acronym":"","url":"https://clinicaltrials.gov/study/NCT04321135","created_at":"2021-01-18T20:56:17.440Z","updated_at":"2024-07-02T16:35:59.024Z","phase":"","brief_title":"Avanzando Juntas: Adapting an Evidence Based Weight Loss Program for Hispanic Breast Cancer Survivors","source_id_and_acronym":"NCT04321135","lead_sponsor":"Medical College of Wisconsin","biomarkers":" LEP","pipe":"","alterations":" ","tags":["LEP"],"overall_status":"Completed","enrollment":" Enrollment 40","initiation":"Initiation: 11/01/2019","start_date":" 11/01/2019","primary_txt":" Primary completion: 07/30/2022","primary_completion_date":" 07/30/2022","study_txt":" Completion: 07/30/2022","study_completion_date":" 07/30/2022","last_update_posted":"2022-12-16"},{"id":"0aea7556-82ea-4ac9-9fd3-c75c76168ace","acronym":"DUET","url":"https://clinicaltrials.gov/study/NCT04132219","created_at":"2021-01-18T20:11:00.398Z","updated_at":"2024-07-02T16:35:59.065Z","phase":"","brief_title":"Daughters, dUdes, Mothers and othErs Fighting Cancer Together","source_id_and_acronym":"NCT04132219 - DUET","lead_sponsor":"University of Alabama at Birmingham","biomarkers":" IL6 • LEP","pipe":"","alterations":" ","tags":["IL6 • LEP"],"overall_status":"Completed","enrollment":" Enrollment 112","initiation":"Initiation: 10/15/2020","start_date":" 10/15/2020","primary_txt":" Primary completion: 02/15/2022","primary_completion_date":" 02/15/2022","study_txt":" Completion: 02/15/2022","study_completion_date":" 02/15/2022","last_update_posted":"2022-12-15"},{"id":"20efeb70-a46d-4b47-9855-0576c986d562","acronym":"","url":"https://clinicaltrials.gov/study/NCT04374747","created_at":"2021-01-18T21:08:05.002Z","updated_at":"2024-07-02T16:36:00.953Z","phase":"","brief_title":"Fruit and Vegetable Intervention in Lactating Women to Reduce Breast Cancer Risk","source_id_and_acronym":"NCT04374747","lead_sponsor":"University of Massachusetts, Amherst","biomarkers":" IL6 • TNFA • CXCL8 • FLT1 • VEGFD • FGF • IL1B • LEP","pipe":"","alterations":" ","tags":["IL6 • TNFA • CXCL8 • FLT1 • VEGFD • FGF • IL1B • LEP"],"overall_status":"Recruiting","enrollment":" Enrollment 400","initiation":"Initiation: 10/24/2019","start_date":" 10/24/2019","primary_txt":" Primary completion: 04/01/2024","primary_completion_date":" 04/01/2024","study_txt":" Completion: 04/01/2024","study_completion_date":" 04/01/2024","last_update_posted":"2022-11-04"},{"id":"5996192f-bb70-43df-9e20-f3b7527b292e","acronym":"WISER Survivor","url":"https://clinicaltrials.gov/study/NCT01515124","created_at":"2021-05-05T15:52:48.906Z","updated_at":"2024-07-02T16:36:02.758Z","phase":"","brief_title":"The Women In Steady Exercise Research (WISER) Survivor Trial","source_id_and_acronym":"NCT01515124 - WISER Survivor","lead_sponsor":"Milton S. Hershey Medical Center","biomarkers":" LEP","pipe":"","alterations":" ","tags":["LEP"],"overall_status":"Completed","enrollment":" Enrollment 450","initiation":"Initiation: 01/01/2012","start_date":" 01/01/2012","primary_txt":" Primary completion: 05/01/2016","primary_completion_date":" 05/01/2016","study_txt":" Completion: 05/01/2016","study_completion_date":" 05/01/2016","last_update_posted":"2022-10-10"},{"id":"e2ba8f73-021f-4815-bd4f-48ebd4e397b8","acronym":"","url":"https://clinicaltrials.gov/study/NCT02278965","created_at":"2021-01-18T10:43:45.075Z","updated_at":"2024-07-02T16:36:05.372Z","phase":"Phase 1","brief_title":"Metformin and Omega-3 Fatty Acids in Woman With a History of Early Stage Breast Cancer","source_id_and_acronym":"NCT02278965","lead_sponsor":"Katherine D. Crew","biomarkers":" IL6 • IGF1 • IGFBP3 • CRP • IGFBP1 • LEP","pipe":"","alterations":" ","tags":["IL6 • IGF1 • IGFBP3 • CRP • IGFBP1 • LEP"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e metformin"],"overall_status":"Completed","enrollment":" Enrollment 19","initiation":"Initiation: 01/22/2015","start_date":" 01/22/2015","primary_txt":" Primary completion: 04/19/2017","primary_completion_date":" 04/19/2017","study_txt":" Completion: 04/19/2017","study_completion_date":" 04/19/2017","last_update_posted":"2022-08-17"},{"id":"c9a34678-366d-442f-ade5-2248a2dd724d","acronym":"","url":"https://clinicaltrials.gov/study/NCT04598984","created_at":"2021-01-19T20:29:46.616Z","updated_at":"2024-07-02T16:36:05.932Z","phase":"","brief_title":"The Role of Serum Adipokines in Predicting Response to Neoadjuvant Therapy in Patients With Rectal Cancer","source_id_and_acronym":"NCT04598984","lead_sponsor":"Istanbul Training and Research Hospital","biomarkers":" LEP","pipe":"","alterations":" ","tags":["LEP"],"overall_status":"Recruiting","enrollment":" Enrollment 60","initiation":"Initiation: 09/01/2020","start_date":" 09/01/2020","primary_txt":" Primary completion: 12/30/2022","primary_completion_date":" 12/30/2022","study_txt":" Completion: 12/31/2022","study_completion_date":" 12/31/2022","last_update_posted":"2022-08-08"},{"id":"847e653b-dff4-4ea5-bd6f-f508321f9602","acronym":"","url":"https://clinicaltrials.gov/study/NCT04850937","created_at":"2021-04-20T14:55:38.600Z","updated_at":"2024-07-02T16:36:06.471Z","phase":"","brief_title":"Effect of Low-dose Esketamine on Postoperative Depression in Patients With Breast Cancer","source_id_and_acronym":"NCT04850937","lead_sponsor":"Yangzhou University","biomarkers":" LEP","pipe":"","alterations":" ","tags":["LEP"],"overall_status":"Completed","enrollment":" Enrollment 90","initiation":"Initiation: 02/10/2021","start_date":" 02/10/2021","primary_txt":" Primary completion: 04/10/2021","primary_completion_date":" 04/10/2021","study_txt":" Completion: 05/10/2022","study_completion_date":" 05/10/2022","last_update_posted":"2022-07-28"},{"id":"20cdb6b4-4d2c-45c3-a0aa-74a2dd4ded1f","acronym":"","url":"https://clinicaltrials.gov/study/NCT04330339","created_at":"2021-01-18T20:58:16.747Z","updated_at":"2024-07-02T16:36:06.933Z","phase":"","brief_title":"Prolonged Nightly Fasting in Breast Cancer Survivors","source_id_and_acronym":"NCT04330339","lead_sponsor":"Massachusetts General Hospital","biomarkers":" HER-2 • IL6 • TNFA • CRP • LEP","pipe":" | ","alterations":" HER-2 positive","tags":["HER-2 • IL6 • TNFA • CRP • LEP"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 positive"],"overall_status":"Completed","enrollment":" Enrollment 40","initiation":"Initiation: 07/24/2020","start_date":" 07/24/2020","primary_txt":" Primary completion: 01/31/2021","primary_completion_date":" 01/31/2021","study_txt":" Completion: 07/05/2022","study_completion_date":" 07/05/2022","last_update_posted":"2022-07-21"},{"id":"8fa87bea-7651-49ab-bb80-07ce6a462f25","acronym":"ECHO","url":"https://clinicaltrials.gov/study/NCT02664441","created_at":"2021-01-18T12:59:12.401Z","updated_at":"2024-07-02T16:36:10.913Z","phase":"Phase 3","brief_title":"Energy Balance \u0026 Weight Loss in Craniopharyngioma-related or Other Hypothalamic Tumors in Hypothalamic Obesity","source_id_and_acronym":"NCT02664441 - ECHO","lead_sponsor":"Seattle Children's Hospital","biomarkers":" CRP • LEP","pipe":"","alterations":" ","tags":["CRP • LEP"],"overall_status":"Completed","enrollment":" Enrollment 42","initiation":"Initiation: 03/01/2016","start_date":" 03/01/2016","primary_txt":" Primary completion: 03/16/2020","primary_completion_date":" 03/16/2020","study_txt":" Completion: 07/31/2020","study_completion_date":" 07/31/2020","last_update_posted":"2022-05-05"}]